摘要
分化型甲状腺癌(DTC)总体预后良好,死亡风险低,其管理重点在于防治肿瘤复发及对复发疾病的妥善处理。^(131)I作为DTC诊治的重要辅助手段,在复发疾病中仍然发挥着独特的诊治作用,主要包括复发灶的定位、摄碘性判断以及针对不可手术切除的摄碘性复发疾病的治疗。准确把握^(131)I在DTC术后复发中的应用指征,将有助于提高综合治疗效果,改善病人预后及生活质量。
Differentiated thyroid cancer(DTC) generally has a good prognosis and a low risk of death.Thus,the management mainly focuses on the prevention and proper treatment of recurrent diseases.As an important auxiliary method for DTC diagnosis and treatment,^(131)I plays a unique role in the recurrent diseases,including the location of recurrent lesions,the judgment of radioiodine(RAI) avidity,and the treatment of unresectable RAI-avid recurrent diseases.Accurate application of ^(131)I in postoperative recurrence of DTC will help to enhance the comprehensive curative effect and improve patients’ prognosis and quality of life.
作者
慕转转
林岩松
MU Zhuan-zhuan;LIN Yan-song(Department of Nuclear Medicine,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College(PUMC)Hospital,Chinese Academy of Medical Sciences&PUMC,Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine,Beijing 100730,China)
出处
《中国实用外科杂志》
CAS
CSCD
北大核心
2021年第8期860-864,共5页
Chinese Journal of Practical Surgery
基金
国家自然科学基金(No.81771875)
中国医学科学院中央级公益性科研院所基本科研业务费专项资金(No.2019XK320009)
国家重点研发计划“政府间国际科技创新合作/港澳台科技创新合作”重点专项(No.2019YFE0106400)。
